These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 25089373)
1. Shortcomings of pertussis vaccines: why we need a third generation vaccine. Poolman JT Expert Rev Vaccines; 2014 Oct; 13(10):1159-62. PubMed ID: 25089373 [TBL] [Abstract][Full Text] [Related]
2. Pertussis vaccination and whooping cough: and now what? Guiso N Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131 [TBL] [Abstract][Full Text] [Related]
3. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007 [TBL] [Abstract][Full Text] [Related]
4. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620 [TBL] [Abstract][Full Text] [Related]
5. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Witt MA; Arias L; Katz PH; Truong ET; Witt DJ Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373 [TBL] [Abstract][Full Text] [Related]
6. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160 [TBL] [Abstract][Full Text] [Related]
7. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization. van den Biggelaar AH; Poolman JT Expert Rev Vaccines; 2016; 15(1):69-80. PubMed ID: 26559122 [TBL] [Abstract][Full Text] [Related]
10. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
11. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021 [TBL] [Abstract][Full Text] [Related]
12. Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses. Sheridan SL; Ware RS; Grimwood K; Lambert SB Vaccine; 2015 Sep; 33(39):5027-30. PubMed ID: 26297874 [TBL] [Abstract][Full Text] [Related]
13. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195 [TBL] [Abstract][Full Text] [Related]
14. Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection. Herzog C Expert Rev Vaccines; 2015; 14(8):1065-72. PubMed ID: 26098640 [TBL] [Abstract][Full Text] [Related]
15. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499 [TBL] [Abstract][Full Text] [Related]
16. Roads to the development of improved pertussis vaccines paved by immunology. Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400 [TBL] [Abstract][Full Text] [Related]
17. New pertussis vaccination approaches: en route to protect newborns? Locht C; Mielcarek N FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832 [TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice. Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641 [TBL] [Abstract][Full Text] [Related]
19. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
20. Do we need a new vaccine to control the re-emergence of pertussis? Mills KH; Ross PJ; Allen AC; Wilk MM Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]